APPlexus is an initiative designed to address educational needs specific to advanced practice providers who care for patients with cancer. These webinars will navigate insights and updates for CAR T-cell therapy for hematologic malignancies, managing adverse events of immune checkpoint inhibitors alone and in combination with chemotherapy and targeted therapies, and review novel antibody drug conjugates as treatments for breast cancer, while delivering innovative, real-time education to nurse practitioners, nurses, physician associates, and other healthcare professionals who care for these patients.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://clinicaloptions.com/events/applexus-spring-2025/16583
- Start Date: 2025-03-22 05:00:00
- End Date: 2025-03-22 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 35500.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 37500.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest